The Wistar Institute

Today's Discoveries, Tomorrow's Cures.

Medical advances begin as scientific advances. The Wistar Institute is an independent nonprofit biomedical research institute dedicated to saving lives through science.
Our Science >
New Therapeutic Approach for Ovarian Cancer Identified

Scientists led by Rugang Zhang demonstrated how a mutation in ovarian clear cell carcinoma can be exploited to design a targeted treatment.
Learn More >
Preclinical Results Show Enhanced Antitumor Response

Dmitry Gabrilovich and his collaborators showed how an investigational drug called enitostat can be combined with an anti-PD1 monoclonal antibody.
Learn More >
Synthetic DNA Vaccine Protects Against Variety of Influenza Viruses

David Weiner and his lab developed a new method of delivering protection and addressing some of the annual challenges faced in trying to combat the spread of the seasonal flu virus.
Learn More >
First-of-its-Kind Research Apprenticeship Approved

Wistar's Biomedical Research Technician (BRT) Apprenticeship has become the first-ever registered, nontraditional apprenticeship program in biomedical research approved by the Pennsylvania Department of Labor & Industry.
Learn More >

Connect with Wistar

Stay up-to-date with Wistar's exciting scientific discoveries and all of our upcoming events.

Wistar Shared Resources

Wistar's Shared Resources augment the power of individual labs with scientific expertise and technologies. They are available to all Wistar investigators, Wistar affiliates, and external researchers on a fee-for-service basis.

Find a Shared Resource >

Meet A Scientist

Qing Chen, M.D., Ph.D., focuses on brain metastasis, a significant clinical challenge due to its rising incidence and limited treatment options. She studies how cancer cells interact with surrounding brain cells to understand how a cancer can become metastatic.

More About Qing's Research >

Support Wistar

Your contribution directly supports Wistar scientists in their efforts to improve cancer medicine and create new vaccines.
Donate >

Giving options >

From The Wistar Wire

August 16, 2017

Career Transition: Reeti Behera, Ph.D., Continues Cancer Research by Applying What She Learned in Lab to Office

Reeti Behera, Ph.D., a talented postdoctoral fellow who has worked in the Weeraratna lab at Wistar since 2014, successfully made the career transition from hands-on bench scientist to a scientific program administrator for the American Association of Cancer Research (AACR). Read More >

August 16, 2017

Wistar Science Highlights: Ovarian Cancer Research, Melanoma Publication Award, Zika Science in Singapore

A new study from Wistar scientists has demonstrated a potential method for treating an aggressive type of ovarian cancer. A young scientist was honored for her melanoma research paper, while another traveled to Singapore to present new data about a Zika vaccine. Read More >

See All News

Press Releases

July 24, 2017

New Therapeutic Approach for Difficult-to-Treat Subtype of Ovarian Cancer Identified

Scientists from The Wistar Institute demonstrate how a mutation in ovarian clear cell carcinoma can be exploited to design a targeted treatment. Read More >